5 Topic Commentaries
Elevating Ocular Surface Care
-
Esen K. Akpek, MD
Ophthalmology
•Wilmer Eye Institute, Johns Hopkins Medicine
SourceWe have to specifically examine the tear film.
-
Preeya K. Gupta, MD
Cornea (Ophthalmology)
•Duke Eye Center, Duke University
SourceOcular surface dysfunction due to dry eye disease is highly prevalent, and a lot of patients are undiagnosed,
-
Thomas Dohlman, MD
Ophthalmology
•Harvard Medical School and Massachusetts Eye and Ear
SourceDry eye disease is a chronic, complex condition, and we don't have a strict playbook to follow for treatment.
-
Anthony St. Leger, PhD
Ophthalmology and Immunology
•University of Pittsburgh School of Medicine; UPMC Vision Institute
SourceThis is the first demonstration that a microbe that lives on the ocular surface could be engineered to deliver a therapeutic that improves eye health,
-
Dave R. Patel, MD
Ophthalmology
•Mayo Clinic
SourceThere are anti-inflammatory medications, neurostimulators that can trigger or increase tear production and sometimes steroids to reduce inflammatory conditions,
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


